Genentech’s Strategic Pivot: The Closure of Its Cancer Immunology Unit
Introduction In a significant and somewhat unexpected move within the biotech industry, Genentech, a subsidiary of Roche, has…
Biogen Expands Immunology Portfolio with Strategic Acquisition
Biogen Inc. has announced the acquisition of Human Immunology Biosciences (HI-Bio) for an upfront payment of $1.15 billion,…